Revealing nascent proteomics in signaling pathways and cell differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 10, 2018, Pages 2353-2358

  Forester, Craig M ^a,b   Zhao, Qian ^a,c   Phillips, Nancy J ^a   Urisman, Anatoly ^d   Chalkley, Robert J ^a   Oses Prieto, Juan A ^a   Zhang, Li ^b,d   Ruggero, Davide ^a,b,d   Burlingame, Alma L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erythropoiesis; mTOR; Proteomics; Puromycin; Translation

Indexed keywords

AZIDE; BIOTIN; DYE; O PROPARGYLPUROMYCIN; POLYPEPTIDE; SAPANISERTIB; STREPTAVIDIN; UNCLASSIFIED DRUG; O-PROPARGYL-PUROMYCIN; PROTEOME; PUROMYCIN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CHEMICAL LABELING; CLICK CHEMISTRY; CONJUGATION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DEVELOPMENT; HUMAN; K-562 CELL LINE; LIQUID CHROMATOGRAPHY; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN SYNTHESIS; TANDEM MASS SPECTROMETRY;

CELL DIFFERENTIATION; CHROMATOGRAPHY, LIQUID; DRUG DISCOVERY; HUMANS; K562 CELLS; PROTEIN BIOSYNTHESIS; PROTEOME; PROTEOMICS; PUROMYCIN; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TOR SERINE-THREONINE KINASES;

EID: 85042947419     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1707514115     Document Type: Article

References (48)

1. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C (2009) Global signatures of protein and mRNA expression levels. Mol Biosyst 5:1512–1526.
2. Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13:227–232.
3. Truitt ML, Ruggero D (2016) New frontiers in translational control of the cancer genome. Nat Rev Cancer 16:288–304.
4. Bowling H, et al. (2014) Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity. Sci Signal 7:ra4.
5. Jovanovic M, et al. (2015) Immunogenetics. Dynamic profiling of the protein life cycle in response to pathogens. Science 347:1259038.
6. Spellman DS, Deinhardt K, Darie CC, Chao MV, Neubert TA (2008) Stable isotopic labeling by amino acids in cultured primary neurons: Application to brain-derived neurotrophic factor-dependent phosphotyrosine-associated signaling. Mol Cell Proteomics 7:1067–1076.
7. Ong S-E, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376–386.
8. Dieterich DC, Link AJ, Graumann J, Tirrell DA, Schuman EM (2006) Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc Natl Acad Sci USA 103:9482–9487.
9. Beatty KE, et al. (2006) Fluorescence visualization of newly synthesized proteins in mammalian cells. Angew Chem Int Ed Engl 45:7364–7367.
10. Hatzenpichler R, et al. (2014) In situ visualization of newly synthesized proteins in environmental microbes using amino acid tagging and click chemistry. Environ Microbiol 16:2568–2590.
11. Deal RB, Henikoff JG, Henikoff S (2010) Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones. Science 328:1161–1164.
12. Ballikaya S, et al. (2014) De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach. Mol Cell Proteomics 13:3446–3456.
13. Howden AJM, et al. (2013) QuaNCAT: Quantitating proteome dynamics in primary cells. Nat Methods 10:343–346.
14. tom Dieck S, et al. (2015) Direct visualization of newly synthesized target proteins in situ. Nat Methods 12:411–414.
15. Ullrich M, et al. (2014) Bio-orthogonal labeling as a tool to visualize and identify newly synthesized proteins in Caenorhabditis elegans. Nat Protoc 9:2237–2255.
16. Aviner R, Geiger T, Elroy-Stein O (2013) Novel proteomic approach (PUNCH-P) reveals cell cycle-specific fluctuations in mRNA translation. Genes Dev 27:1834–1844.
17. Liu J, Xu Y, Stoleru D, Salic A (2012) Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin. Proc Natl Acad Sci USA 109:413–418.
18. Schneider RK, et al. (2016) Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nat Med 22:288–297.
19. Signer RAJ, Magee JA, Salic A, Morrison SJ (2014) Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509:49–54.
20. Signer RAJ, et al. (2016) The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs. Genes Dev 30:1698–1703.
21. Blanco S, et al. (2016) Stem cell function and stress response are controlled by protein synthesis. Nature 534:335–340.
22. Hettmer S, et al. (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. eLife 4:e09436.
23. Mateju D, et al. (2017) An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J 36:1669–1687.
24. Hsieh AC, Truitt ML, Ruggero D (2011) Oncogenic AKTivation of translation as a therapeutic target. Br J Cancer 105:329–336.
25. Laplante M, Sabatini DM (2013) Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 126:1713–1719.
26. Feldman ME, et al. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7:e38.
27. Thoreen CC, et al. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:109–113.
28. Hsieh AC, et al. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485:55–61.
29. Janes MR, et al. (2013) Efficacy of the investigational mTOR kinase inhibitor MLN0128/ INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia 27:586–594.
30. Mellacheruvu D, et al. (2013) The CRAPome: A contaminant repository for affinity purification-mass spectrometry data. Nat Methods 10:730–736.
31. Hsieh AC, et al. (2010) Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 17:249–261.
32. Kim AR, et al. (2015) Bmi-1 regulates extensive erythroid self-renewal. Stem Cell Reports 4:995–1003.
33. England SJ, McGrath KE, Frame JM, Palis J (2011) Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 117:2708–2717.
34. Chen C, et al. (2013) Snx3 regulates recycling of the transferrin receptor and iron assimilation. Cell Metab 17:343–352.
35. Payne EM, et al. (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood 118:903–915.
36. Bottardi S, et al. (2014) The IKAROS interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis. PLoS Genet 10:e1004827.
37. Laurenti E, et al. (2015) CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16:302–313.
38. Mullenders J, et al. (2015) Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms. J Exp Med 212:1833–1850.
39. Pitzonka L, et al. (2014) The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse. PLoS One 9:e97628.
40. Chambers SM, et al. (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5:e201.
41. Sincennes M-C, et al. (2016) The LMO2 oncogene regulates DNA replication in hematopoietic cells. Proc Natl Acad Sci USA 113:1393–1398.
42. Aebersold R, Burlingame AL, Bradshaw RA (2013) Western blots versus selected reaction monitoring assays: Time to turn the tables? Mol Cell Proteomics 12:2381–2382.
43. von Lindern M, et al. (1999) The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94:550–559.
44. Narla A, et al. (2011) Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 118:2296–2304.
45. Narla A, Vlachos A, Nathan DG (2011) Diamond Blackfan anemia treatment: Past, present, and future. Semin Hematol 48:117–123.
46. Ebert BL, et al. (2005) An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: Identification of dexamethasone-responsive genes by microarray. Blood 105: 4620–4626.
47. Flygare J, Karlsson S (2007) Diamond-Blackfan anemia: Erythropoiesis lost in translation. Blood 109:3152–3154.
48. Zhao Q, et al. (2017) Broad-spectrum kinase profiling in live cells with lysine-targeted sulfonyl fluoride probes. J Am Chem Soc 139:680–685.